article thumbnail

More than 50 Access Scheme pharmacies have closed since 2022, NPA claims

The Pharmacist

This represents 4% of the 1,444 pharmacies eligible to claim funding under the scheme set up to 'capture the pharmacies that are most important for patient access, those […] The post More than 50 Access Scheme pharmacies have closed since 2022, NPA claims appeared first on The Pharmacist.

134
134
article thumbnail

Opinion: Herding cats: It’s past time to include pets in disease surveillance

STAT

Since 2022, more than 100 domesticated cats in the United States have had confirmed infections — some house pets, some barn cats, some feral — with high mortality, although mortality data remain undocumented on federal sites.

363
363
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

GPhC November pass rate drops again to 2022 levels

The Pharmacist

This brings the pass rates back down almost to November 2022 levels of 56%, following a 10% rise to 66% in November 2023. And it comes as summer pass rates have seen a steady decline […] The post GPhC November pass rate drops again to 2022 levels appeared first on The Pharmacist.

Diabetes 121
article thumbnail

STAT+: FTC slams PBMs for boosting specialty drug prices at the expense of the U.S. health care system

STAT

billion in revenue by dispensing medicines to treat cancer, HIV, heart disease and other serious illnesses at prices that exceeded their estimated acquisition costs between 2017 and 2022. Specifically, the companies were able to generate more than $7.3 Continue to STAT+ to read the full story…

article thumbnail

Opinion: I’m the director of the Center for Medicare. Here’s how we executed the first round of drug price negotiation

STAT

The historic Inflation Reduction Act of 2022 has fundamentally improved the affordability of and access to prescription drugs for millions of people with Medicare. The law laid out aggressive timelines for implementing the Medicare Drug Price Negotiation Program.

article thumbnail

Heart failure market to grow at 9.6 per cent CAGR in 7MM during 2022-32

Express Pharma

billion in 2022 to $33.7 per cent CAGR in 7MM during 2022-32 appeared first on Express Pharma. With pipeline approvals of varying mechanisms of action and an influx of newly diagnosed patients, the heart failure (HF) market is expected to grow at a 9.6 per cent compound annual growth rate (CAGR) from $13.5

article thumbnail

STAT+: AbbVie snaps up CAR-T company in a deal worth $2.1 billion

STAT

  Capstan launched in 2022 and has raised around $340 million from OrbiMed, Vida Ventures, RA Capital, Polaris Partners, and the venture teams at Pfizer, Bayer, Eli Lilly and Company, and Bristol Myers Squibb.   AbbVie will pay up to $2.1 billion in cash when the deal closes, according to a press release.

294
294